STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
9
Codes C/M, not in net · $6.1M priced
What the filings say about ORI
Insiders, 180 days
-$2.0M net sold
1 buyer · 3 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-05-12
Planned sales (Form 144), 90 days
$875.1K
3 notices
OLD Republic International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, OLD REPUBLIC INTERNATIONAL CORP insiders sold a net $2.0M of stock across 114 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 1, 2025.
The trade is 115.0% of the 12,244 shares held after it.
2 other insiders sold within 30 days.
Insider activity: SVPUnderwriting & Distribution LANGE JEFFREY sold about $615.9K of ORI on Jul 29, 2026, the largest insider sale at the company since 2021; 2 other insiders sold within 30 days.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Aug 21, 2025.
The trade is 16.0% of the 82,205 shares held after it.
2 other insiders sold within 30 days.
Insider activity: Executive Vice President OBERST STEPHEN J sold about $577.0K of ORI on Jul 28, 2026, the largest insider sale at the company since 2021; 2 other insiders sold within 30 days.
Nobody has filed for crossing 5%. That is a fact, not missing data.
ORI planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
MONROE CAROLYN
Filed 2026-09-01
$184.2K
MONROE CAROLYN
Filed 2026-08-11
$75.6K
Jeffrey Lange
Filed 2026-07-30
$615.3K
OBERST STEPHEN J
Filed 2026-07-28
$576.9K
Executive pay vs shareholder return · Mr. Smiddy
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$5.9M
$8.8M
$2.5M
+80%
+48%
2022
$4.5M
$5.1M
$2.1M
+43%
+38%
2021
$2.4M
$3.3M
$1.2M
+34%
+25%
2020
$1.9M
$1.6M
$1.3M
-8%
-7%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.0M sold by insiders over 180 days, $875.1K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$9.7B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ORI
FY Dec 2025
$9.1B
FY Dec 2024
$8.2B
FY Dec 2023
$7.3B
FY Dec 2022
$8.1B
FY Dec 2021
$9.3B
Jun 2026
$2.5B
Mar 2026
$2.4B
Dec 2025
$2.4B
Sep 2025
$2.4B
Jun 2025
$2.2B
Mar 2025
$2.1B
Dec 2024
$2.0B
Sep 2024
$2.3B
At each fiscal year end
Single quarter
Net margin, TTM
+11.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ORI
FY Dec 2025
+10.2%
FY Dec 2024
+10.4%
FY Dec 2023
+8.2%
FY Dec 2022
+8.5%
FY Dec 2021
+16.4%
Jun 2026
+12.9%
Mar 2026
+13.8%
Dec 2025
+8.6%
Sep 2025
+11.5%
Jun 2025
+9.3%
Mar 2025
+11.6%
Dec 2024
+5.2%
Sep 2024
+14.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM ORI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity ORI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt ORI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+18.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ORI
FY Dec 2025
+16.2%
FY Dec 2024
+14.2%
FY Dec 2023
+9.5%
FY Dec 2022
+10.5%
FY Dec 2021
+23.5%
Jun 2026
+18.6%
Mar 2026
+17.2%
Dec 2025
+16.2%
Sep 2025
+13.0%
Jun 2025
+14.6%
Mar 2025
+12.7%
Dec 2024
+14.2%
Sep 2024
+15.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ORI
FY Dec 2025
+3.2%
FY Dec 2024
+3.1%
FY Dec 2023
+2.3%
FY Dec 2022
+2.7%
FY Dec 2021
+6.4%
Jun 2026
+3.7%
Mar 2026
+3.5%
Dec 2025
+3.2%
Sep 2025
+2.8%
Jun 2025
+3.1%
Mar 2025
+2.8%
Dec 2024
+3.1%
Sep 2024
+3.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ORI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ORI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
8.43x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ORI
FY Dec 2025
12.27x
FY Dec 2024
11.17x
FY Dec 2023
14.00x
FY Dec 2022
10.55x
FY Dec 2021
4.84x
Jun 2026
8.97x
Mar 2026
9.83x
Dec 2025
12.27x
Sep 2025
12.79x
Jun 2025
10.89x
Mar 2025
12.78x
Dec 2024
11.17x
Sep 2024
10.09x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value ORI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield ORI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.29x
P/E over trailing EPS growth of 29%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing ORI
FY Dec 2025
0.83x
FY Dec 2024
0.21x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.03x
Jun 2026
0.31x
Mar 2026
0.30x
Dec 2025
0.83x
Sep 2025
n/a
Jun 2025
0.23x
Mar 2025
0.66x
Dec 2024
0.21x
Sep 2024
0.86x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ORI ranks highest on profitability (62nd percentile) and risk and compliance (59th), and lowest on growth (55th), among Insurance peers.
Profitability
62
Inputs
Return on equity+18.6% · 66 pct, sector of 116
Return on assets+3.7% · 58 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
55
Inputs
Revenue growth, YoY+11.0% · 55 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
58
Inputs
Net Form 4 buying (codes P and S), 180d-$2.0M · 55 pct, sector of 100
Insider buyers, 180d1 · 62 pct, sector of 101
Risk and compliance
59
Inputs
Short interest, % of float+5.0% · 34 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+4.9% · 85 pct, sector of 110
3 not measured: Financial health, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ORI filings, in plain words
Are OLD Republic International insiders buying or selling ORI?
In the 180 days to 2026-10-28, OLD Republic International insiders were net sellers, a net $2.0M: $12.0K of purchases and $2.0M of sales reported on Form 4, by 1 buyer and 3 sellers.
Have members of Congress traded ORI?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Jefferson Shreve dated 2025-05-12.
Are there planned insider sales of ORI?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $875.1K of stock; the latest, by MONROE CAROLYN, was filed 2026-09-01.
Read the full summary
In the 180 days to 2026-10-28, OLD Republic International insiders were net sellers of ORI, a net $2.0M across purchases and sales reported on Form 4 by 1 buyer and 3 sellers. Sales outweighed purchases more than tenfold by value. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in ORI, none in the last year; the latest on record is a sale by Jefferson Shreve dated 2025-05-12. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $875.1K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.